Clinical Trial Update: Cell-Based Therapy for White Matter Repair in Periventricular Leukomalacia [EARLY_Phase 1]

View source ↗

Summary

An early-phase cell-based therapy trial for white matter repair in periventricular leukomalacia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Demyelinating Diseases
• Hypoxic-ischemic Encephalopathy
• Neonatal Encephalopathy
• Periventricular Leukomalacia
• White Matter Disease

Snippet

Sponsor: MGAM LLC | Conditions: Periventricular Leukomalacia, White Matter Disease | EARLY_Phase 1 | Status: WITHDRAWN